151 related articles for article (PubMed ID: 18373644)
1. IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas.
Wang H; Arun BK; Wang H; Fuller GN; Zhang W; Middleton LP; Sahin AA
Breast J; 2008; 14(3):261-7. PubMed ID: 18373644
[TBL] [Abstract][Full Text] [Related]
2. Roles of insulin-like growth factor-I (IGF-I) and IGF-I binding protein-2 (IGFBP2) and -5 (IGFBP5) in developing chick limbs.
McQueeney K; Dealy CN
Growth Horm IGF Res; 2001 Dec; 11(6):346-63. PubMed ID: 11914022
[TBL] [Abstract][Full Text] [Related]
3. HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger.
Maru D; Middleton LP; Wang S; Valero V; Sahin A
Cancer; 2005 Mar; 103(5):900-5. PubMed ID: 15643600
[TBL] [Abstract][Full Text] [Related]
4. Significant expression of IGFBP2 in breast cancer compared with benign lesions.
Busund LT; Richardsen E; Busund R; Ukkonen T; Bjørnsen T; Busch C; Stalsberg H
J Clin Pathol; 2005 Apr; 58(4):361-6. PubMed ID: 15790698
[TBL] [Abstract][Full Text] [Related]
5. IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity.
Probst-Hensch NM; Steiner JH; Schraml P; Varga Z; Zürrer-Härdi U; Storz M; Korol D; Fehr MK; Fink D; Pestalozzi BC; Lütolf UM; Theurillat JP; Moch H
Clin Cancer Res; 2010 Feb; 16(3):1025-32. PubMed ID: 20103684
[TBL] [Abstract][Full Text] [Related]
6. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer.
Cabioglu N; Yazici MS; Arun B; Broglio KR; Hortobagyi GN; Price JE; Sahin A
Clin Cancer Res; 2005 Aug; 11(16):5686-93. PubMed ID: 16115904
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor binding proteins IGFBP3, IGFBP4, and IGFBP5 predict endocrine responsiveness in patients with ovarian cancer.
Walker G; MacLeod K; Williams AR; Cameron DA; Smyth JF; Langdon SP
Clin Cancer Res; 2007 Mar; 13(5):1438-44. PubMed ID: 17332286
[TBL] [Abstract][Full Text] [Related]
8. alphaB-crystallin as a marker of lymph node involvement in breast carcinoma.
Chelouche-Lev D; Kluger HM; Berger AJ; Rimm DL; Price JE
Cancer; 2004 Jun; 100(12):2543-8. PubMed ID: 15197794
[TBL] [Abstract][Full Text] [Related]
9. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
Sharif MA; Mamoon N; Mushtaq S; Khadim MT
J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313
[TBL] [Abstract][Full Text] [Related]
10. Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.
Naeem M; Nasir A; Aman Z; Ahmad T; Samad A
J Ayub Med Coll Abbottabad; 2008; 20(3):23-6. PubMed ID: 19610508
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types.
Wang H; Rosen DG; Wang H; Fuller GN; Zhang W; Liu J
Mod Pathol; 2006 Sep; 19(9):1149-56. PubMed ID: 16729015
[TBL] [Abstract][Full Text] [Related]
12. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study.
Wang H; Wang H; Zhang W; Fuller GN
Technol Cancer Res Treat; 2006 Jun; 5(3):195-9. PubMed ID: 16700616
[TBL] [Abstract][Full Text] [Related]
14. High-level SLP-2 expression and HER-2/neu protein expression are associated with decreased breast cancer patient survival.
Cao W; Zhang B; Liu Y; Li H; Zhang S; Fu L; Niu Y; Ning L; Cao X; Liu Z; Sun B
Am J Clin Pathol; 2007 Sep; 128(3):430-6. PubMed ID: 17709317
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 8 expression in breast carcinoma: associations with androgen receptor and prostate-specific antigen expressions.
Tanaka A; Kamiakito T; Takayashiki N; Sakurai S; Saito K
Virchows Arch; 2002 Oct; 441(4):380-4. PubMed ID: 12404063
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of osteopontin in patients with triple-negative breast cancer.
Wang X; Chao L; Ma G; Chen L; Tian B; Zang Y; Sun J
Eur J Clin Invest; 2008 Jun; 38(6):438-46. PubMed ID: 18452545
[TBL] [Abstract][Full Text] [Related]
17. HYOU1/Orp150 expression in breast cancer.
Stojadinovic A; Hooke JA; Shriver CD; Nissan A; Kovatich AJ; Kao TC; Ponniah S; Peoples GE; Moroni M
Med Sci Monit; 2007 Nov; 13(11):BR231-239. PubMed ID: 17968289
[TBL] [Abstract][Full Text] [Related]
18. Relation between hemostatic parameters and prognostic/predictive factors in breast cancer.
Yigit E; Gönüllü G; Yücel I; Turgut M; Erdem D; Cakar B
Eur J Intern Med; 2008 Dec; 19(8):602-7. PubMed ID: 19046726
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.
Saha S; Ali S; Ghanem M; Soni M; Wiese D; Arora M; Singh T; Iddings D
Ann Surg Oncol; 2009 Feb; 16(2):276-80. PubMed ID: 19050967
[TBL] [Abstract][Full Text] [Related]
20. CXCR4 membrane expression in node-negative breast cancer.
Blot E; Laberge-Le Couteulx S; Jamali H; Cornic M; Guillemet C; Duval C; Hellot MF; Pille JY; Picquenot JM; Veyret C
Breast J; 2008; 14(3):268-74. PubMed ID: 18373506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
